Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Biophytis S.A.
ALBPSCurrent price
0.34 EUR
-0.015 EUR (-4.17%)
Last closed
0.36 EUR
Company
www.biophytis.com
ISIN
FR0012816825
Sector
Healthcare
Industry
Biotechnology
Exchange
Euronext Paris
Capitalization
1 649 701 EUR
Yield for 12 month
-89.11 %
1Y
3Y
5Y
10Y
15Y
ALBPS
Biophytis S.A., a clinical-stage biotechnology company, focuses on the development of therapeutics that slow the degenerative processes and improve functional outcomes for patients suffering from age-related diseases. Its therapeutics targets and activates key biological resilience pathways that can protect against and counteract the effects of the multiple biological and environmental stresses, including inflammatory, oxidative, metabolic, and viral stresses that lead to age-related diseases. The company's lead drug candidate is BIO101, an orally administered small molecule in development to treat neuromuscular diseases, including sarcopenia, Duchenne muscular dystrophy (DMD), and obesity, as well as treatment of severe respiratory failure in patients suffering from COVID-19. It also develops BIO201, an orally administered small molecule for the treatment of retinopathies, including dry age-related macular degeneration, and Stargardt disease. Biophytis SA has a collaboration agreement with AFM-Telethon for the development of its BIO101 for the treatment of DMD. The company was incorporated in 2006 and is headquartered in Paris, France. Address: Sorbonne University, Paris, France, 75005
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
2.04 EURP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Current Year
-810 805 EUR
Last Year
-488 704 EUR
Current Quarter
–
Last Quarter
–
Key Figures ALBPS
1 year
3 years
5 years
10 years
EBITDA
-11 918 720 EUR
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-65.37 %
PEG Ratio
–
Return On Equity TTM
-1244.4 %
Wall Street Target Price
2.04 EUR
Revenue TTM
–
Book Value
-1.23 EUR
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
-4.22 EUR
Diluted Eps TTM
-4.22 EUR
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics ALBPS
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History ALBPS
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:400
Payout Ratio
–
Last Split Date
03.05.2024
Dividend Date
–
Stock Valuation ALBPS
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
–
Enterprise Value EBITDA
-0.3851
Price Book MRQ
2.2489
Financials ALBPS
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators ALBPS
For 52 weeks
0.28 EUR
3.55 EUR
50 Day MA
0.43 EUR
Shares Short Prior Month
–
200 Day MA
0.86 EUR
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart